Molecular mechanisms of eukaryotic ribosome biogenesis
In plain English
AI plain-English summaryRibosomes—the protein-making machines inside every cell—are being linked to inherited and acquired blood cancers like myelodysplasia and acute leukaemia, and researchers want to understand exactly how defects in their assembly trigger disease. This matters because recent evidence suggests that faults in a basic "housekeeping" process—how cells build ribosomes from their component parts—can drive cancer. Yet the molecular details of ribosome assembly remain poorly understood. The team is mapping the three-dimensional shapes of key assembly proteins and testing their roles in living cells using model organisms. If successful, this fundamental science will reveal the precise pathways that go wrong in ribosome-related blood cancers. That knowledge could improve diagnosis and, in the longer term, guide new treatments for patients with these devastating diseases. The work is curiosity-driven—it aims to understand a core cellular process at the molecular level—but past discoveries in fundamental cell biology have repeatedly opened unexpected routes to cancer therapies. A deeper grasp of how ribosomes are built may similarly yield future clinical applications.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Research GrantPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know